COVID-19: Caring for Patients and Communities, Uncompensated Care, Drug Prices, Medicare, Medicaid, 340B Drug Pricing Program PhRMA report misleads on drug costs Feb 11, 2021 By Tom Nickels
340B Drug Pricing Program AHA Statement on Most Favored Nation Model Interim Final Rule Nov 20, 2020 By Tom Nickels
Rural issues, Novel Coronavirus (SARS-CoV-2/COVID-19), COVID-19: Coverage and Reimbursement What’s next for rural hospitals? Additional COVID-19 relief and beyond Nov 18, 2020 By Tom Nickels
Novel Coronavirus (SARS-CoV-2/COVID-19), COVID-19: Coverage and Reimbursement, Post-Acute Care AHA Letter on Resetting the IMPACT Act in Next COVID-19 Relief Package Jun 24, 2020 By Tom Nickels
Drug Prices, 340B Drug Pricing Program Latest PhRMA “report” attempt to divert attention away from skyrocketing drug prices Dec 19, 2019 By Tom Nickels
340B Drug Pricing Program, Drug Prices Report misrepresents 340B program to deflect from sky high drug prices Nov 22, 2019 By Tom Nickels
Drug Price Transparency, Drug Prices Flawed Report on Specialty Drug Spending Fails to Place Blame on Drug Companies Sep 10, 2019 By Tom Nickels
